Evidence map›Paper›PMID 24385927›Full record

ArticlePLoS genetics2013

The PAF complex and Prf1/Rtf1 delineate distinct Cdk9-dependent pathways regulating transcription elongation in fission yeast.

Jean Mbogning, Stephen Nagy, Viviane Pagé, Beate Schwer, Stewart Shuman, Robert P Fisher, Jason C Tanny

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 59 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Decoding histone ubiquitylation.Frontiers in cell and developmental biology · 2022
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Jean MbogningDepartment of Pharmacology and Therapeutics, McGill University, Montreal, Canada.
Stephen NagyDepartment of Pharmacology and Therapeutics, McGill University, Montreal, Canada.
Viviane PagéDepartment of Pharmacology and Therapeutics, McGill University, Montreal, Canada.
Beate SchwerDepartment of Microbiology and Immunology, Weill Cornell Medical College, New York, New York, United States of America.
Stewart ShumanMolecular Biology Program, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America.
Robert P FisherDepartment of Structural and Chemical Biology, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.
Jason C TannyDepartment of Pharmacology and Therapeutics, McGill University, Montreal, Canada.
McGill University · CACornell University · USIcahn School of Medicine at Mount Sinai · USMemorial Sloan Kettering Cancer Center · US

Funding

mRNA Capping EnzymesR01GM052470 · NIGMS · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI SCHWER, BEATE, SHUMAN, STEWART H · 1995 to 2019
$9.9M
Chemical Genetic Analysis of the Human Cell CycleR01GM105773 · NIGMS · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI FISHER, ROBERT P · 2013 to 2016
$1.3M
CIHR MOP-97890NIGMS NIH HHS GM105773NIGMS NIH HHS GM52470NIGMS NIH HHS R01 GM052470NIGMS NIH HHS R01 GM105773
6 · The paper itself

Abstract

Cyclin-dependent kinase 9 (Cdk9) promotes elongation by RNA polymerase II (RNAPII), mRNA processing, and co-transcriptional histone modification. Cdk9 phosphorylates multiple targets, including the conserved RNAPII elongation factor Spt5 and RNAPII itself, but how these different modifications mediate Cdk9 functions is not known. Here we describe two Cdk9-dependent pathways in the fission yeast Schizosaccharomyces pombe that involve distinct targets and elicit distinct biological outcomes. Phosphorylation of Spt5 by Cdk9 creates a direct binding site for Prf1/Rtf1, a transcription regulator with functional and physical links to the Polymerase Associated Factor (PAF) complex. PAF association with chromatin is also dependent on Cdk9 but involves alternate phosphoacceptor targets. Prf1 and PAF are biochemically separate in cell extracts, and genetic analyses show that Prf1 and PAF are functionally distinct and exert opposing effects on the RNAPII elongation complex. We propose that this opposition constitutes a Cdk9 auto-regulatory mechanism, such that a positive effect on elongation, driven by the PAF pathway, is kept in check by a negative effect of Prf1/Rtf1 and downstream mono-ubiquitylation of histone H2B. Thus, optimal RNAPII elongation may require balanced action of functionally distinct Cdk9 pathways.

Indexed as

Transcription, GeneticBinding SitesChromatinCyclin-Dependent Kinase 9HistonesPhosphorylationRNA, MessengerSchizosaccharomycesSchizosaccharomyces pombe ProteinsSignal TransductionTranscriptional Elongation FactorsChromatinCyclin-Dependent Kinase 9HistonesRNA, MessengerSchizosaccharomyces pombe ProteinsSpt5 protein, S pombeTranscriptional Elongation Factors

Identifiers

PMID24385927
PMCPMC3873232
OpenAlexW2068524813

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.